1-Benzyl-1,2,3,4-tetrahydroisoquinoline Derivatives and Optically Pure Isomers as Novel Promising Multidrug Resistance (MDR) Reversing Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|6|5|387-392

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.6, Iss.5, 2009-07, pp. : 387-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Multidrug Resistance to Antitumor Agents (MDR)

By  

Current Medicinal Chemistry, Vol. 9, Iss. 2, 2002-01 ,pp. : 159-193

Bentham Science Publishers

Access to resources Recommend Favorite

Derivatives of 1,2,3,4-tetrahydroisoquinoline-7-carboxylic Acid as Novel Fibrinogen Receptor Antagonists

By  

Medicinal Chemistry, Vol. 5, Iss. 2, 2009-03 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Based Nanoparticles as Inherent Reversing Agents of Multidrug Resistance in Cancer

By  

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6714-6729

Bentham Science Publishers

Access to resources Recommend Favorite

1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), An Endogenous Neurotoxin, Induces Dopaminergic Cell Death Through Apoptosis

By Shavali S.   Ebadi M.  

Neurotoxicology, Vol. 24, Iss. 3, 2003-06 ,pp. : 417-424

Elsevier

Access to resources Recommend Favorite

MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion

By Lööscher Wolfgang   Delanty Norman  

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 711-713

Future Medicine

Access to resources Recommend Favorite